Alterity Research Development from 2010 to 2025
| ATH Stock | 0.01 0 11.11% |
Research Development | First Reported 1999-12-31 | Previous Quarter 5.7 M | Current Value 8.7 M | Quarterly Volatility 2.5 M |
Check Alterity Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alterity Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 2.9 K, Other Operating Expenses of 11.3 M or Total Operating Expenses of 11.2 M, as well as many indicators such as . Alterity financial statements analysis is a perfect complement when working with Alterity Therapeutics Valuation or Volatility modules.
Alterity | Research Development |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Alterity Stock Analysis
When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.